Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma-Reference-Cited by-同舟云学术

Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma

Published:2017-06-29 Issue:43 Volume:8 Page:74178-74187
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Ze-Han¹,Zhang Qi²³,Ding Yi-Jie⁴,Ren Ying-Hui³,Yang Hui-Peng³,Xi Qing³,Cheng Ying-Nan³,Miao Guo-Lin³,Liu Hong-Kun³,Li Cai-Xia²,Yan Wen-Qiang⁵,Li Yan³,Xue Zhenyi³,Zhang Lijuan³,Li Xin-Ye⁶,Zhao Chen-Long⁶,Da Yurong³,Wu Xian-Zhong²,Chen Jun-Qiang⁷,Zhang Rongxin⁸³,Li Zhi-Gang⁹⁶²

Affiliation:

1. Nankai Clinical College, Tianjin Medical University, Tianjin, P.R. China

2. Institute of Integrative Medicine Therapy for Acute Abdominal Diseases of Tianjin, Nankai Hospital, Tianjin, P. R. China

3. Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Basic Medical College, Tianjin Medical University, Tianjin, P.R. China

4. First Central Clinical College, Tianjin Medical University, Tianjin, P.R. China

5. Department of Thoracic Surgery, Nankai Hospital, Nankai District, Tianjin, P. R. China

6. General Hospital, Tianjin Medical University, Tianjin, P.R. China

7. Department of Radiotherapy, Fujian Provincial Tumor Hospital, Affiliated Tumor Hospital of Fujian Medical University, Fuzhou, P.R. China

8. Laboratory of Immunology and Inflammation, Guangdong Pharmaceutical University, Guangzhou, P.R. China

9. Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical College, Haikou City, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interference with CHD1L inhibits proliferation, promotes apoptosis and G2/M phase arrest and enhances cisplatin sensitivity of ovarian cancer cells through PLK1;2023-04-20

2. A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers;Frontiers in Molecular Biosciences;2023-03-23

3. circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade;Cancer Cell International;2021-05-25

4. The high expression of CHD1L and its clinical significance in human solid tumors;Medicine;2021-03-12

5. Diversity roles of CHD1L in normal cell function and tumorigenesis;Biomarker Research;2021-03-04